Opportunities and challenges of RiPP-based therapeutics

This article is licensed under aCreative Commons Attribution 3.0 Unported Licence.Isabel P.-M. Pfeiffer, Maria-Paula Schr öder, Silja Mordhorst Ribosomally synthesised and post-translationally modified peptides (RiPPs) are highly promising candidates for drug discovery and development, but challenges remain. To cite this article before page numbers are assigned, use the DOI form of citation above. The content of this RSS Feed (c) The Royal Society of Chemistry

Source: RSC - Nat. Prod. Rep. latest articles - February 27, 2024 Category: Chemistry Authors: Isabel P.-M. Pfeiffer Source Type: research